How does fish oil supplementation protect against atrial fibrillation following coronary artery by-pass surgery? - A cellular study.
Phase 1
- Conditions
- ATRIAL FIBRILLATION (AF) FOLLOWING CORONARY ARTERY BY-PASS GRAFT (CABG)SURGERY.MedDRA version: 8.1Level: LLTClassification code 10003658Term: Atrial fibrillation
- Registration Number
- EUCTR2006-001451-35-GB
- Lead Sponsor
- South Manchester University NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
AL PATIENTS UNDER GOING ISOLATED CORONARY ARTERY BY-PASS SURGERY WHO ARE NOT KNOWN TO HAVE PRE- EXISTING ATRIAL FIBRILLATION AND ARE NOT TAKING ANY REGULAR ANTI-ARRYTHMIC DRUGS.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
PATIENTS WHO HAVE CONCOMMITANT VALVE SURGERY, PATIENTS ON ANTI-ARRYTHMIC DRUGS, PATIENTS WHO ARE KNOWN TO HAVE PRE-EXISTING ATRIAL FIBRILLATION.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: TO EVALUATE THE LIKELY BENEFICIAL EFFECT OF OMACOR ( OMEGA 3 FATTY ACIDS) SUPPLEMENT ON THE INCIDENCE OF ATRIAL FIBRILLATION FOLLOWING CORONARY ARTERY BY-PASS GRAFT (CABG) SURGERY.;Secondary Objective: TO ELUCIDATE THE MECHANISM OF ANTI-ARRYTHMIC ACTION OF OMACOR.;Primary end point(s): ATRIAL FIBRILLATION AFTER CABG.
- Secondary Outcome Measures
Name Time Method